This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,708 Years Active: 2002
Title: The Innovative Contributions of Mary E Dolan
Introduction
Mary E Dolan is a notable inventor based in Oak Park, IL (US). He has made significant strides in the field of cancer research, particularly through his innovative therapies. His work focuses on the development of treatments that can effectively combat solid tumors.
Latest Patents
Mary E Dolan holds a patent for "Chelerythrine-based therapies for cancer." This patent highlights the use of Chelerythrine as an effective inhibitor of solid tumor growth. It is particularly noteworthy for its extreme cytotoxicity when combined with chemotherapeutic agents that directly damage DNA. This innovative approach has the potential to enhance cancer treatment outcomes.
Career Highlights
Throughout his career, Mary E Dolan has dedicated himself to advancing cancer therapies. His research has contributed to a deeper understanding of how certain compounds can be utilized to inhibit tumor growth. His work is recognized for its potential impact on the future of cancer treatment.
Collaborations
Mary E Dolan has collaborated with esteemed colleagues in the field, including Ralph R Weichselbaum and Donald W Kufe. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer therapies.
Conclusion
Mary E Dolan's contributions to cancer research through his patent on Chelerythrine-based therapies exemplify the importance of innovation in medicine. His work continues to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile